Alwin Capital

Venture Capital

Alwin Capital is a Venture Capital firm based in Beijing, China.

China-based venture capital firm specializing in early-stage life science investments, including biotech, gene therapy, cell therapy, and diagnostics.

Early Stage
Biotech
Headquarters
Beijing, China
Founded
2015
AUM
$500.0M
Portfolio Companies
3
Total Investments
4
Last Investment
Apr 2021
Geographic Focus
China
Use investor data through the API.
Example request
curl "https://indexed.vc/api/v1/investors/alwin-capital?depth=slim" -H "X-API-Key: YOUR_API_KEY"

Indexed holds 3 portfolio companies and 4 funding rounds for this investor. The full record is or through the API.

Investment Thesis

Invests in early-stage life science companies through theme-focused research, backing innovators across gene therapy, cell therapy, diagnostics, and medical robotics in China.

It was founded in 2015. It has made 4 investments. Its portfolio includes Immorna, Synbio Technologies and EdiGene. Focus areas include Biotech.

Portfolio3

Co-investors20

Sign up to view co-investors

20 co-investors across 21 shared portfolio companies — who they back alongside, and how often they lead.

Venture Capital ×17 · Corporate VC ×1 · Private Equity ×1 · 17 shared rounds

Investment History

Data from Indexed.vcUpdated

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

Alwin Capital on Indexed.vc
<a href="https://indexed.vc/investors/alwin-capital"><img src="https://indexed.vc/api/badge/investor/alwin-capital" alt="Alwin Capital on Indexed.vc" width="260" height="76" /></a>